Vortex Surgical Recalls I2 Injection Kits Over Potential Sterility Breach
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Vortex Surgical Inc. is recalling 14,789 I2 Injection Kits due to packaging seal defects that could compromise sterility and lead to patient infection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Vortex Surgical Inc. has initiated a voluntary recall of the Vortex Surgical I2 Injection Kit (Model VS0500). The recall was prompted by the discovery of potential voids in the seals of the Tyvek pouches used for the kits. These defects could compromise the sterile barrier of the medical device, potentially leading to bioburden contamination and subsequent patient infection.
Which Products Are Affected
The recall involves the following specific product details:
- Product Name: Vortex Surgical I2 Injection Kit, VS0500
- Recall Number: Z-1252-2026
- Lot Number: 2411012
- Pouch UDI: 810123480920
- Box UDI: 810123481330
A total of 14,789 units are affected, including 8,651 units distributed within the United States and 6,138 units distributed internationally. In the U.S., the product was distributed to 31 states: AL, AR, AZ, CA, CT, FL, HI, IA, IL, IN, KY, MA, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, RI, SC, SD, TN, TX, WA, WI, and VA. International distribution included Australia, Chile, China, France, Germany, India, Ireland, Italy, Japan, Korea, Mexico, Netherlands, Philippines, Poland, Puerto Rico, Spain, Switzerland, Taiwan, United Kingdom, and Vietnam.
What You Should Do
Vortex Surgical Inc. began notifying affected customers via a letter sent on December 16, 2025. Healthcare facilities and distributors should immediately check their inventory for Lot 2411012 and sequester any remaining units to prevent use. For information regarding returns or further instructions, contact Vortex Surgical Inc. at their headquarters: 4 Research Park Dr Ste 124, Saint Charles, MO 63304.
Why This Matters
The integrity of a sterile barrier is critical for medical devices used in surgical procedures. Voids in the packaging seal can allow microorganisms to contaminate the device, posing a serious risk of infection to patients during clinical use.
Source
This information is based on an official recall report from the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category